Navigation Links
Frost & Sullivan Acknowledges ISTO Technologies' Role in Developing Advanced Biologic Products for Bone Healing
Date:10/14/2008

s," observes Ishwarakrishnan. "The HyA component may provide supplementary biological cues necessary for cells to grow and for the tissue to develop, thus making InQu a versatile scaffold, superior to any osteoconductive material in the market."

The InQu Bone Graft Extender offers several advantages over existing synthetic bone graft substitutes including its unique ability to support the normal process of endochondral bone formation. It also eliminates the potential risk of infection that is common with allograft transplants.

ISTO Technologies has a team of committed scientists and staff working towards delivering high-quality orthobiologic products to the medical community. InQu has already won clearance from Food and Drug Administration (FDA) as a bone graft extender and substitute. The company has several InQu- related patents pending and intends to develop additional applications for the biomaterial technology in the near future.

"The company's development pipeline includes NuQu(TM), a cell-based injectable formulation of juvenile chondrocytes for nucleus regeneration of the spinal disc," notes Ishwarakrishnan. "In addition to this, the company is in clinical trials with DeNovo(R) ET, its scaffold-free living cartilage graft based on its patented cell based technology platform, to repair and regenerate damaged knee cartilage."

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in new products and technologies within its industry. The recipient company has shown innovation by launching a broad line of emerging products and technologies.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance thr
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today ... been appointed to the Company,s Board of Directors.  Dr. ... LLC, the manager and advisor to the funds of ... impressive accomplishments have made it an important company in ... Board of Directors," commented Dr. Baker.  "We look forward ...
(Date:2/9/2010)... HUNTINGTON BEACH, California and AMSTERDAM , ... leader in molecular cancer diagnostics, announced today that,it ... New York State ,Department of Health. The ... company to receive,commercial samples of MammaPrint, its FDA-cleared ... With this latest permit, Agendia has now obtained ...
(Date:2/8/2010)... China , Feb. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... modernized traditional Chinese medicine ("TCM") based in Chengdu, ... ended December 31, 2009 . , , ... $14.9 Million, Net Income Increased, ... of $0.11 on a diluted basis, ...
(Date:2/8/2010)... MEDFORD, Mass. , Feb. 8 /PRNewswire/ ... to working with maternal-fetal-medicine doctors by attending the ... "Biocell Center has been working with perinatologists and ... Kate Torchilin , CEO of Biocell Center Corporation. ... have on mothers and families and we are ...
Breaking Biology Technology:Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors 2Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors 3Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 2Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 3Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 4Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 5Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 6Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 7Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 8Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 9Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 10Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 11Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 12Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 13Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 14Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 15Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 16Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 17Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine 2
... Kingdom,s lead centre for the developing technology to counter ... and Physical Sciences Research Council. , Almost 7m ... and Knowledge Centre - the Centre for Secure Information ... Institute of Electronics, Communications and Information Technology (ECIT) in ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... venous reflux disease, today announced its,plans to present at the ... 2008, at The New York Palace Hotel in New York ... Chief Executive,Officer. , VNUS, ...
... ARBOR, Mich., Nov. 21 MichBio, the association ... service providers to its fourth annual Expo on ... Financial ShowPlace in Novi, MI. The MichBio ... industry professionals.,In addition, this year,s event attracted 56 ...
Other Biology Technology:Queen's secures £25M for UK's cyber safety 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 3
(Date:2/8/2010)... UK springs and summers has been accelerating, according ... in the scientific journal Global Change Biology ... from 12 UK research institutions, universities and conservation ... so far of long-term changes in the seasonal ... and terrestrial environments in the UK. , ...
(Date:2/8/2010)... wealth of data about how cells respond to stimuli, ... a daunting challenge. In a study published online ... have developed a novel method of interpreting data from ... offering a glimpse into the future of high-throughput cell ... through a microscope at cells as they change appearance ...
(Date:2/8/2010)... University] Around 30 to 40 million years ago, ... assemblage capitalized on falling levels of atmospheric carbon dioxide ... CO2 supply that, like a fuel-injection system in a ... energy. , The rise of C4 grasses is not ... make up to 20 percent of our planet,s vegetational ...
Breaking Biology News(10 mins):Will earlier springs throw nature out of step? 2Method of the future uses single-cell imaging to identify gene interactions 2Brown biologist solves mystery of tropical grasses' origin 2Brown biologist solves mystery of tropical grasses' origin 3New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure 28R 29 56965 1New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure 28R 29 56965 2New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure 28R 29 56965 3Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 1Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 2Bangkok Hospital Group and IBM Collaborate on Smarter Healthcare Initiative 56962 1Bangkok Hospital Group and IBM Collaborate on Smarter Healthcare Initiative 56962 2Bangkok Hospital Group and IBM Collaborate on Smarter Healthcare Initiative 56962 3Bangkok Hospital Group and IBM Collaborate on Smarter Healthcare Initiative 56962 4
... at the Case Western Reserve University School of Medicines ... impacting the three billion people exposed to malaria every ... D., and Christopher L. King, M.D., Ph.D. published in ... (PLoS Medicine), novel findings proving new antibodies inhibit infection ...
... times as likely as U.S-born children to suffer from lead ... Department study, and the risk is highest among the most ... poisoning in 2002, published online in the American Journal of ... abroad within the previous six months were 11 times as ...
... -- Two deadly and highly infectious viruses -- both potential ... new drug developed by scientists at Weill Cornell Medical College ... related, newly recognized zoonotic viruses that can spread from their ... pigs, horses and humans. , The mode of transmission ...
Other Biology News:CWRU School of Medicine has evidence vaccine against malaria will reduce disease 2Study shows immigrant children are at increased risk of lead poisoning 2Study shows immigrant children are at increased risk of lead poisoning 3Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 2Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 3
... The InnoCyte Laminin-Based 96-well Cell Invasion ... capacity of cells using laminin as a ... potential anti-metastatic agents in vitro in a ... pore size is appropriate for all types ...
... are designed for the study of protein:protein ... method. Proteins that interact with GST•Tag™, ... are copurified using affinity resins for the ... a spin filter. The complexes are eluted ...
Kit containing MACS equipment and reagents for immunopurification of proteins....
... biomarker discovery projects require screening through ... distinguish clinically relevant data from normal ... Manager is now available to help ... and data flood inherent to biomarker ...
Biology Products: